VAERS reports by lot

GSK Hepatitis B lot 2PG39: VAERS reports

29 VAERS reports list lot 2PG39 as a GSK Hepatitis B vaccine, received between 2023-05-10 and 2024-09-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological920%
Musculoskeletal817%
General / Systemic (non-local)817%
Gastrointestinal613%
Dermatological (non-injection-site)511%
Injection-site / Local reaction511%
Respiratory37%
Cardiac / Cardiovascular12%
Allergic / Anaphylactic12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas5
Florida3
Indiana3
Michigan2
California2
South Carolina1
North Carolina1
Ohio1
Iowa1
Colorado1
New York1
Alabama1

Reports by month received

2023-054
2023-065
2023-073
2023-083
2023-094
2023-101
2023-122
2024-013
2024-021
2024-051
2024-081
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.